6533b7d0fe1ef96bd125a615

RESEARCH PRODUCT

Clinical characteristics and outcomes of thymoma-associated myasthenia gravis

Carlos CasasnovasYolanda MorgadoMaría Teresa Gómez-caravacaLuis QuerolAlba Ramos-fransiHelena Pérez-pérezRodrigo ÁLvarez-velascoElisabeth MartínezVelina NedkovaJanina Turon-sansJuan Carlos TrujilloIvonne JericóEduard GallardoEduard GallardoRicard Rojas-garcíaGuillermo FernándezBeatriz Vélez-gómezAna L. Pelayo-negroSonia SegoviaAlicia Martínez-piñeiroElena Cortés-vicenteTeresa SevillaCarmen ParadasMaría Asunción MartínMaría Dolores MendozaAdolfo López De MunainMarina Arribas-velascoAntonio Guerrero-solaGerardo Gutiérrez-gutiérrezIsabel IllaJulio Pardo

subject

medicine.medical_specialtyThymomaThymomaEnfermedad del sistema nerviosoMiastenia gravischemical and pharmacologic phenomenaGastroenterology03 medical and health sciences0302 clinical medicineDisease severityRecurrenceInternal medicinehemic and lymphatic diseasesMyasthenia GravismedicineHumansIn patient030212 general & internal medicineneoplasmsNeurologíaMyasthenia gravisRetrospective Studiesbusiness.industryHazard ratioOdds ratioThymus Neoplasmsthymomamedicine.diseaseThymectomyPrognosisConfidence intervalMyasthenia gravisThymomEfectos fisiológicossurgical procedures operativeNeurologyMulticenter studySignos y síntomasNeurology (clinical)Neoplasm Recurrence LocalbusinessTimoma030217 neurology & neurosurgery

description

[Background and purpose] Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma recurrence or unresectable lesions entail a worse prognosis of MG.

10.1111/ene.14820http://hdl.handle.net/10261/262175